# A131 OUTCOMES AND COMPLICATIONS OF THERAPEUTIC ERCP IN DIFFERENT AGE GROUPS

**Authors:** E Hazan, C Na, A Zarrin, A Mokhtar, K Khalaf, N Gimpaya, M Meleka, D Tham, S P Abal, W Mhalawi, D Chopra, S Gupta, S Jugnundan, N Calo, C Teshima, J Mosko, G May, S Grover

PMC · DOI: 10.1093/jcag/gwad061.131 · 2024-02-14

## TL;DR

This study examines how age affects the success and safety of ERCP procedures, finding that while ERCP remains safe, success rates decrease and procedure times increase in older patients.

## Contribution

The study provides evidence on the impact of age on ERCP outcomes, particularly in elderly patients.

## Key findings

- ERCP success rates decline with increasing age, from 91.3% in patients under 40 to 84.9% in those over 80.
- Procedure duration increases significantly in older age groups, but complication rates remain consistent across all age groups.

## Abstract

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a vital procedure for hepatobiliary disease management. Though it boasts high overall success rates, the impact of patient age on outcomes remains uncertain, especially amongst elderly patients. With an aging population, it is crucial to determine the efficacy and safety of ERCP in different age groups.

This study assesses ERCP success and complication rates across age groups. Our objective is to investigate whether ERCP remains a reliable and safe procedure for patients of all ages, particularly the elderly.

A database with retrospective data from consecutive patients undergoing ERCP at a Canadian tertiary care centre between 2011 and 2020 was utilized. Baseline patient characteristics and indications for ERCP were collected. Outcomes included procedural success, complications, and procedure duration. Patients were categorized into four age groups: ampersand:003C40, 40-65, 65-80, and ampersand:003E80, with a specific sub-analysis for patients ampersand:003C80 and ampersand:003E80.

This study included 6132 patients. Significant disparities were observed in comorbid conditions (pampersand:003C0.0001), ASA status (pampersand:003C0.0001), and the use of anticoagulants or antiplatelet agents (pampersand:003C0.0001). The most common indications for ERCP were gallstones (45.1%), jaundice (19.2%), and ductal lesions (12.8%), with no significant variation among the age groups (p=0.5983). There was a significant difference in procedural success (p=0.0005), with declining success in older age groups (ampersand:003C40 = 91.3%, 40-65 = 87.4%, 65-80 = 86.2%, ampersand:003E80 = 84.9%), and this difference remained significant in the ampersand:003C80 and ampersand:003E80 sub-analysis (p=0.0133). While mean procedure duration was longer in older age groups (pampersand:003C0.0001), incidence of complications did not vary across all groups (p values [EH1] = 0.1532-0.7622) or patients ampersand:003C80 and ampersand:003E80 (p= 0.0769-0.7128).

ERCP maintains a high success rate and safety profile across all age groups; however, success rates decline and procedure times increase significantly in older patients.

ERCP outcomes across age groups

None

---
Source: https://tomesphere.com/paper/PMC10871885